These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7981906)

  • 21. Immunoquantitation of thromboxane synthase in human tissues.
    Nüsing R; Ullrich V
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():307-10. PubMed ID: 1825558
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation.
    Purkerson ML; Joist JH; Yates J; Valdes A; Morrison A; Klahr S
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):193-7. PubMed ID: 3855542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for two distinct and functionally important sites of enhanced thromboxane production after bilateral ureteral obstruction in the rat.
    Harris KP; Yanagisawa H; Schreiner GF; Klahr S
    Clin Sci (Lond); 1991 Aug; 81(2):209-13. PubMed ID: 1653665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.
    Sakariassen KS; Alberts P; Fontana P; Mann J; Bounameaux H; Sorensen AS
    Future Cardiol; 2009 Sep; 5(5):479-93. PubMed ID: 19715412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arachidonic acid metabolites produced by platelet-depleted human blood monocytes: a possible role in thrombogenesis.
    Jones CM; Hall ER; Hester JP; Wu KK
    Am J Hematol; 1989 Jul; 31(3):145-52. PubMed ID: 2741910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein.
    Mundel P; Gilbert P; Kriz W
    J Histochem Cytochem; 1991 Aug; 39(8):1047-56. PubMed ID: 1856454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thromboxane synthase expression co-localizes with infiltrating macrophages in renal allograft biopsies.
    Berkes EA; Croker BP; Barri YM; Peterson JC; Wilcox CS; Ramos EL
    Kidney Int; 1995 Oct; 48(4):1344-6. PubMed ID: 8569098
    [No Abstract]   [Full Text] [Related]  

  • 30. Thromboxane A2 interferes with a disposal process of aggregated protein in glomeruli.
    Nagamatsu T; Nagao T; Nomura Y; Suzuki Y
    Jpn J Pharmacol; 1997 Dec; 75(4):381-90. PubMed ID: 9469644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.
    Hammarström S; Falardeau P
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3691-5. PubMed ID: 410024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.
    Kömhoff M; Grone HJ; Klein T; Seyberth HW; Nüsing RM
    Am J Physiol; 1997 Apr; 272(4 Pt 2):F460-8. PubMed ID: 9140046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis. Effects on renal hemodynamics.
    Lianos EA; Andres GA; Dunn MJ
    J Clin Invest; 1983 Oct; 72(4):1439-48. PubMed ID: 6685136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of thromboxane A2 inhibition and antagonism on prostaglandin and leukotriene synthesis in glomerular immune injury.
    Lianos EA; Bresnahan BA
    J Lab Clin Med; 1999 Nov; 134(5):478-82. PubMed ID: 10560941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
    Nagao T; Nagamatsu T; Suzuki Y
    Eur J Pharmacol; 1996 Nov; 316(1):73-80. PubMed ID: 8982653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis.
    Hartner A; Pahl A; Brune K; Goppelt-Struebe M
    Inflamm Res; 2000 Jul; 49(7):345-54. PubMed ID: 10959556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thromboxane A(2) causes retarded clearance of aggregated protein in glomeruli of nephritic mice.
    Nagao T; Koseki J; Suzuki Y; Nagamatsu T
    Eur J Pharmacol; 2001 Feb; 413(2-3):271-9. PubMed ID: 11226403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrin deposition and adaptive changes in glomerular procoagulant and fibrinolytic activities in rat renoprival nephropathy.
    Ruedin P; Mougenot B; Ruedin D; Rondeau E; Sraer JD; Lacave R; Kanfer A
    J Exp Pathol (Oxford); 1990 Apr; 71(2):269-78. PubMed ID: 2331409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal microthrombosis following endotoxin infusion may be mediated by lipoxygenase products.
    Schaub RG; Ochoa R; Simmons CA; Lincoln KL
    Circ Shock; 1987; 21(4):261-70. PubMed ID: 3107853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies against membrane proteins of the rat glomerulus. Immunochemical specificity and immunofluorescence distribution of the antigens.
    Miettinen A; Dekan G; Farquhar MG
    Am J Pathol; 1990 Oct; 137(4):929-44. PubMed ID: 1699424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.